A comprehensive comparison of fluorescence in situ hybridization and cytology for the detection of upper urinary tract urothelial carcinoma: A systematic review and meta-analysis
- PMID: 30593189
- PMCID: PMC6314722
- DOI: 10.1097/MD.0000000000013859
A comprehensive comparison of fluorescence in situ hybridization and cytology for the detection of upper urinary tract urothelial carcinoma: A systematic review and meta-analysis
Abstract
Objective: To compare the relative effectiveness of fluorescence in situ hybridization (FISH) and cytology in diagnosing upper urinary tract urothelial carcinoma (UUT-UC) and to evaluate the advantages and potential deficiencies of FISH analysis.
Methods: We performed a complete systematic review based on studies from PubMed/Medline, Embase, Web of Science, Ovid, Web of Knowledge, and Cochrane Library. We identified 2031 patients with strict criteria in 14 individual studies between January 2005 to November 2017 in accordance to preferred reporting items for systematic reviews and meta-analysis (PRISMA) guidelines, we summarized the test performance using bivariate random effects models.
Results: FISH was superior to cytology in terms of pooled sensitivities (84.0%, 95% confidence interval [CI] 74.4-90.5% vs 40.0%, 95% CI 33.6-46.7%). FISH and cytology were similar to each other in terms of pooled specificities, which were 89.5% (95% CI 85.3-92.6%) for FISH and 95.9% (95% CI 91.2-98.1%) for cytology.
Conclusion: We confirm the superiority of FISH over cytology in terms of sensitivity and find similar diagnostic outcomes between them based on systematic analysis. Therefore, we demonstrate that FISH is extremely sensitive while still very reliable with a relatively low error rate for diagnosing UUT-UC.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures



Similar articles
-
Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma.Cancer Genet Cytogenet. 2009 Mar;189(2):93-7. doi: 10.1016/j.cancergencyto.2008.10.015. Cancer Genet Cytogenet. 2009. PMID: 19215789
-
Utility of The Paris System (TPS) for upper urinary tract cytopathology: correlation with histology follow-up and UroVysion fluorescence in situ hybridization (FISH) analysis.J Am Soc Cytopathol. 2024 Mar-Apr;13(2):149-155. doi: 10.1016/j.jasc.2023.12.003. Epub 2024 Jan 3. J Am Soc Cytopathol. 2024. PMID: 38341300
-
Comparison of urinary cytology and fluorescence in situ hybridization in the detection of urothelial neoplasia: An analysis of discordant results.Diagn Cytopathol. 2019 Apr;47(4):282-288. doi: 10.1002/dc.24108. Epub 2018 Nov 12. Diagn Cytopathol. 2019. PMID: 30417563
-
A review of urinary cytology in the setting of upper tract urothelial carcinoma.J Am Soc Cytopathol. 2021 Jan-Feb;10(1):29-35. doi: 10.1016/j.jasc.2020.06.011. Epub 2020 Jul 17. J Am Soc Cytopathol. 2021. PMID: 32792229 Review.
-
Diagnostic performance of fluorescence in situ hybridization (FISH) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis.Int J Clin Oncol. 2022 Oct;27(10):1605-1615. doi: 10.1007/s10147-022-02216-7. Epub 2022 Jul 18. Int J Clin Oncol. 2022. PMID: 35856125
Cited by
-
Diagnostic value comparison of CellDetect, fluorescent in situ hybridization (FISH), and cytology in urothelial carcinoma.Cancer Cell Int. 2021 Sep 6;21(1):465. doi: 10.1186/s12935-021-02169-3. Cancer Cell Int. 2021. PMID: 34488763 Free PMC article.
-
Genetic architecture of mammographic density as a risk factor for breast cancer: a systematic review.Clin Transl Oncol. 2023 Jun;25(6):1729-1747. doi: 10.1007/s12094-022-03071-8. Epub 2023 Jan 13. Clin Transl Oncol. 2023. PMID: 36639603
-
Adolescent loneliness as a predictor of adult obesity: a longitudinal analysis from the HUNT study, Norway.BMC Public Health. 2025 Aug 13;25(1):2751. doi: 10.1186/s12889-025-23872-0. BMC Public Health. 2025. PMID: 40804380 Free PMC article.
-
Management of Low-grade Upper Tract Urothelial Carcinoma: An Unmet Need.Rev Urol. 2020;22(1):1-8. Rev Urol. 2020. PMID: 32523465 Free PMC article.
-
Diagnostic performance of an immunoassay based on urine exfoliated cell enrichment nanotechnology for upper tract urothelial carcinoma: a retrospective, monocentric study.BMC Urol. 2022 Nov 25;22(1):194. doi: 10.1186/s12894-022-01122-4. BMC Urol. 2022. PMID: 36434570 Free PMC article.
References
-
- Skacel M, Fahmy M, Brainard JA, et al. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol 2003;169:2101–5. - PubMed
-
- Roupret M, Babjuk M, Comperat E, et al. European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol 2018;73:111–22. - PubMed
-
- Oosterlinck W, Solsona E, van der Meijden AP, et al. European Association of Urology EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol 2004;46:147–54. - PubMed
-
- Shan Z, Wu P, Zheng S, et al. Evaluation of upper urinary tract tumors by FISH in Chinese patients. Cancer Genet Cytogenet 2010;203:238–46. - PubMed
-
- Mills IW, Laniado ME, Patel A. The role of endoscopy in the management of patients with upper urinary tract transitional cell carcinoma. BJU Int 2001;87:150–62. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources